Michael Celano
2018 - Recro Pharma
In 2018, Michael Celano earned a total compensation of $1.2M as Chief Operating Officer at Recro Pharma, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $84,925 |
|---|---|
| Option Awards | $240,000 |
| Salary | $415,261 |
| Stock Awards | $403,200 |
| Other | $45,488 |
| Total | $1,188,874 |
Celano received $415.3K in salary, accounting for 35% of the total pay in 2018.
Celano also received $84.9K in non-equity incentive plan, $240K in option awards, $403.2K in stock awards and $45.5K in other compensation.
Rankings
In 2018, Michael Celano's compensation ranked 8,330th out of 14,244 executives tracked by ExecPay. In other words, Celano earned more than 41.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,330 out of 14,244 | 42nd |
Division Manufacturing | 3,302 out of 5,759 | 43rd |
Major group Chemicals And Allied Products | 1,239 out of 2,122 | 42nd |
Industry group Drugs | 1,035 out of 1,811 | 43rd |
Industry Pharmaceutical Preparations | 807 out of 1,385 | 42nd |
Source: SEC filing on March 20, 2019.
Celano's colleagues
We found two more compensation records of executives who worked with Michael Celano at Recro Pharma in 2018.